Approval Locks & Sign-Off Trails Built for Pharma Marketing Teams

Why MLR Review Keeps Breaking Down In Email And Shared Drives

Pharma marketing teams live inside a version-control nightmare that most other industries never have to think about, because every video, from a physician-facing detail piece to a DTC campaign spot, has to move through Medical, Legal, and Regulatory review before anyone can even think about a media buy. That usually means a chain of email attachments, a shared drive folder with fifteen file names that all say "FINAL," and a reviewer in Legal who is marking up frame 4:12 while someone in Regulatory is looking at a version that got re-exported an hour ago. When a regulator comes asking who approved a specific claim in a specific cut, that email trail is not evidence, it is a liability.

A Locked Cut Is Your Evidence, Not Just Your Final File

With PlayPause, once Medical, Legal, and Regulatory sign off, the cut locks. Nobody can quietly swap the file underneath the approval, and nobody can claim later that they were reviewing something different than what actually shipped. That lock is basically the whole point of MLR review done right, because the value isn't just getting to "approved," it's being able to prove, six months or two years later, exactly which frames, which claims, and which reviewers signed off on the asset that aired. Generic review tools were not built with pharma's regulatory exposure in mind, they were built for creative feedback, and that gap is where a lot of compliance risk quietly lives.

Every Comment Timestamped To The Frame It Touches

MLR reviewers don't leave feedback the way a creative director does. They leave feedback the way an auditor does, tied to a specific claim, a specific super, a specific frame where a drug's risk information needs to sit on screen a beat longer. PlayPause timestamps every comment to the exact frame it was left on, so "the fair balance text needs to hold two more seconds" isn't a note buried in an email, it's attached to frame 412 forever, visible to Medical, Legal, and Regulatory at the same time. That's timecoded feedback doing the job it was actually meant to do in a regulated industry.

Medical, Legal, And Regulatory Working Off One Source Of Truth

At the end of the day, MLR review fails when the three reviewers aren't looking at the same version at the same time. PlayPause's multi-stakeholder review setup puts Medical, Legal, and Regulatory in the same room, on the same cut, with their own comment threads that don't get lost or overwritten. Because PlayPause prices per workspace and not per seat, adding a fourth or fifth reviewer, a brand director, an outside regulatory consultant, doesn't turn into a licensing negotiation. You just add them.

What An Exportable Sign-Off Trail Actually Looks Like

That exported trail is the artifact your compliance team actually wants sitting in a folder, not a screenshot of a Slack thread and not a "per my last email" chain. It shows who reviewed, what they saw, when they signed off, and that the file that aired is the file that was approved. If your team has ever had to reconstruct an approval history for an internal audit or an outside counsel request, you already know how much time this saves versus digging through inboxes.

Sharing That Doesn't Leak Unapproved Claims

Pharma video assets carry real regulatory risk if they leak before MLR sign-off, so sharing security matters here in a way it doesn't for most industries. PlayPause lets you control exactly who can view a cut, whether reviewers need to be invited by name, and whether a link expires once the review window closes. That's basic hygiene most teams skip until something goes wrong.

• Locked cuts that can't be swapped after sign-off
• Frame-accurate comments tied to specific claims and supers
• One exportable, dated record of every approval
• Flat per-workspace pricing so MLR, brand, and agency partners all get seats

Built To Replace The Tools That Weren't Built For This

Most video review tools were designed for editors and creative directors chasing a look, not for a team that has to defend a claim in front of a regulator. We built the approval lock and the sign-off trail because we kept hearing from pharma marketing leads that their real bottleneck wasn't the creative, it was proving the approval happened. If your team is comparing tools, our pricing page is the fastest way to see whether the flat-workspace model actually fits a regulated review chain, and it's worth reading how financial services compliance teams use the same lock-and-trail mechanic under FINRA scrutiny, since the underlying problem, proving who approved what and when, is basically the same one MLR review has. Groups like the American Marketing Association have written plenty about the growing compliance burden on marketing teams, and video is usually the least documented part of that burden.

Get your next MLR cut locked, timestamped, and audit-ready before it ever reaches a media buyer, start a PlayPause workspace today.